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Sir, 26 
The impact of CTX-M-producing bacteria on animal health remains unclear.
1
 The CTX-M-2 27 
enzyme was first identified in a Salmonella Mbandaka strain isolated from faeces of a 4-28 
month old child.
2
 Later on, CTX-M-2-producing Enterobacteriaceae have also been reported 29 
in faeces from healthy poultry and horses.
1,3-5
 In this study, we describe the molecular 30 
characterisation of different blaCTX-M-2-carrying plasmids in multidrug-resistant E. coli 31 
isolates recovered from cases of diseased horses. From November 2008 through June 2010, 5 32 
cephalosporin-resistant E. coli isolates were obtained from diseased horses hospitalised at the 33 
Faculty of Veterinary Medicine, Ghent University, Belgium. The isolates were recovered 34 
from horses with an abdominal fistula (E. coli 2657), abdominal wound infection (E. coli 35 
3744), peritonitis (E. coli 1443), funiculitis (E. coli 1454) and arthritis (E. coli 4410) 36 
(Supplementary Table 1). Most horses received a prolonged empirical therapy with several 37 
antimicrobial agents, such as β-lactams, aminoglycosides and fluoroquinolones. 38 
Antimicrobial susceptibility testing of the E. coli isolates was assessed by the disc diffusion 39 
method and interpreted according to the guidelines of the Antibiogram Committee of the 40 
French Society for Microbiology (CA-SFM) (Supplementary Table 1).
6
 PCRs to screen for 41 
extended-spectrum β-lactamase genes were performed.5 All isolates harboured the plasmid-42 
encoded blaCTX-M-2 gene. E. coli 4410 and 3744 also carried a narrow-spectrum blaTEM-1 gene. 43 
The epidemiologic relationship among the isolates was studied by pulsed field gel 44 
electrophoresis (PFGE).
3
 XbaI PFGE revealed no genetic relatedness between the isolates 45 
(data not shown). Plasmid transfer experiments were then carried out.
5
 Briefly, E. coli J5, 46 
resistant to rifampicin, was used as the recipient strain.
3
 Conjugation experiments were 47 
performed overnight in Luria-Bertani broth at 37°C with a donor/recipient ratio of 1:5. 48 
Transconjugants were selected on MacConkey agar plates (Oxoid LTD, Basingstoke, 49 
Hampshire, England) supplemented with ceftiofur (8 mg/L) and rifampicin (250 mg/L). The 50 
antimicrobial susceptibility of the transconjugants was also determined
3
 to identify the co-51 
transferred non-β-lactam resistance (Table 1). The blaCTX-M-2-carrying plasmids were 52 
extracted from the transconjugants and were further characterized by EcoRI RFLP 53 
(Restriction Fragment Length Polymorphism) analysis and Southern blot hybridisation.
3
 The 54 
plasmids pB4-25
5
, p1684Sa02
3
 and p04-9275
1
 were included in this analysis. The 55 
incompatibility (Inc) group of each blaCTX-M-2-carrying plasmid was defined by the PCR-56 
based replicon typing method.
7
 The genetic environment of blaCTX-M-2 was investigated as 57 
described.
8
 The different genetic regions (integron cassette array, IntI1 to ISCR1, ISCR1 to 58 
blaCTX-M-2, and blaCTX-M-2 to 3’-CS) were defined by PCR and the sizes were compared with 59 
known genetic regions present on the blaCTX-M-2-carrying plasmids pB4-25
5
, p1684Sa02 60 
(accession number EF592570)
3
 and p04-9275 (accession number EF592571)
1
. Integron 61 
cassette arrays were also further characterized by sequencing (Table 1).
8
  62 
All isolates contained a high-molecular-weight conjugative blaCTX-M-2-carrying plasmid (>100 63 
kb).  64 
Plasmids p1443, p1454, p2657, and p3744 belonged to IncHI1 group and only plasmid p4410 65 
belonged to IncFIB (Table 1). To our knowledge, this is the first time that blaCTX-M-2 is 66 
identified on IncHI1 and IncFIB plasmids. RFLP analysis of plasmid DNA revealed the same 67 
fingerprint pattern for 3 out of 4 IncHI1 plasmids (supplementary figure 1). The differences 68 
seen in RFLP patterns for the IncHI1 plasmids may possibly reflect the rapid evolution of 69 
these plasmids. Southern blot hybridisation with a blaCTX-M-2 probe showed a > 10kb EcoRI 70 
fragment for all plasmids (supplementary figure 1). Characterisation of the genetic 71 
environment showed that blaCTX-M-2 was part of novel complex class 1 integrons (Table 1). 72 
The gene cassette array of the complex class 1 integron located on the IncHI1 plasmids 73 
differed in size with known gene cassette arrays of blaCTX-M-2-carrying complex class 1 74 
integrons (Table 1). Sequencing of the 1664-bp cassette array revealed the association of the 75 
trimethoprim resistance gene cassette dfrA17 and the streptomycin/spectinomycin resistance 76 
gene cassette aadA5. The IncFIB plasmid p4410 showed the same gene cassette array, dfrA1-77 
aadA1, as pB4-25 and p1684Sa02 but the size of the IntI1-ISCR1 region of plasmid p4410 78 
was approximately 15-20 kb in comparison to the known size of 5000 bp (Table 1). The 79 
common region 1 (ISCR1) was found to be linked to the blaCTX-M-2 gene, as reported.
1
 All 80 
these results may indicate that ISCR1 mobilized the blaCTX-M-2 gene from one integron to 81 
another through rolling circle transposition, a phenomenon that has been reported.
1 
82 
Together, these findings show the recent emergence of blaCTX-M-2-producing E. coli in 83 
diseased horses. Previous reports have shown that blaCTX-M-2 is consistently linked with 84 
ISCR1 and located on IncHI2 plasmids from bacteria of human and animal origin.
1,3-5
 The 85 
fact that blaCTX-M-2 was now found on IncHI1 and IncFIB plasmids suggests the mobility of 86 
blaCTX-M-2 via ISCR1 between plasmids of different incompatibility groups. The potential for 87 
transposition of blaCTX-M-2 has health implications since extended-spectrum cephalosporins 88 
are extensively used in human and veterinary medicine. Indeed, the horses from this study 89 
received a prolonged treatment with different antimicrobial agents to recover from an 90 
infection with an ESBL (Extended-Spectrum β-Lactamase)-producing bacterium.  91 
The flexibility of blaCTX-M-2 also highlights the need to develop appropriate means to control 92 
dissemination of this gene and associated resistance genes.  93 
Therefore, comparative genomic analysis of different plasmids carrying blaCTX-M-2 might be 94 
useful to fully understand their evolution, plasticity and spread. While blaCTX-M-2 has 95 
frequently been detected in human pathogens,
1
 this is the first report of blaCTX-M-2-producing 96 
E. coli isolated from diseased animals and more specifically horses. The emergence of blaCTX-97 
M-2 is therefore a clear cause for concern. 98 
 99 
 100 
Acknowledgements 101 
We thank Mrs. Nathalie Van Ryselberghe and Isabelle Monchaux for their skilled technical 102 
assistance.  103 
 104 
Funding 105 
This work was supported by internal funding. 106 
 107 
Transparency declarations 108 
None to declare 109 
 110 
References 111 
1. Smet A, Martel A, Persoons D et al. Broad-spectrum β-lactamases among 112 
Enterobacteriaceae of animal origin: molecular aspects, mobility and impact on 113 
public health. FEMS Microbiol Rev 2010; 34: 295-316.  114 
2. Poupart MC, Chanal C, Sirot D et al. Identification of CTX-2, a novel cefotaximase 115 
from a Salmonella mbandaka. Antimicrob Agents Chemother 1991; 35:1498-500.  116 
3. Bertrand S, Weill FX, Cloeckaert A et al. Clonal Emergence of extended-spectrum β-117 
lactamase (CTX-M-2)-producing Salmonella enterica Serovar Virchow isolates with 118 
reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and 119 
France (2000 to 2003). J Clin Microbiol 2006; 44:2897-903.  120 
4. Karczmarczyk M, Abbott Y, Walsh C  et al. Characterisation of multidrug resistant 121 
Escherichia coli from animals presenting at a university veterinary hospital. Applied 122 
Environ Microbiol 2011; DOI: 10.1128/AEM.00599-11. 123 
5. Smet A, Martel A, Persoons D et al. Comparative analysis of extended-spectrum β-124 
lactamase-carrying plasmids from different members of Enterobacteriaceae isolated 125 
from poultry, pigs and humans: evidence for a shared β-lactam resistance gene pool? J 126 
Antimicrob Chemother 2009; 63:1286-8.  127 
6. Comité de l’Antibiogramme de la Société Française de microbiologie report 2003. 128 
Members of the SFM Antibiogram Committee. Int J Antimicrob Agents 2003; 21:364-129 
91. 130 
7. Carattoli A, Bertini A, Villa L et al. Identification of plasmids by PCR-based replicon 131 
typing. J Microbiol Methods 2005; 63:219-28.  132 
8. Lévesque C, Piché L, Larose C et al. PCR mapping of integrons reveals several novel 133 
combinations of resistance genes. Antimicrob Agents Chemother 1995; 39:185-91.  134 
 135 
Table 1. Characteristics the blaCTX-M-2-carrying plasmids (>100 kb) analysed in this study 136 
plasmid 
nr. 
co-transferred 
antimicrobial resistance
b Inc group 
Complex class 1 integron 
 
 cassette array       IntI1 to ISCR1         ISCR1 to blaCTX-M-2            blaCTX-M-2 to 3’-CS 
pB4-25
a TET, SUL, TMP, STR, 
4GC
 HI2 
dfrA1-aadA1
c
  
(1586 bp) 
5000 bp 2805 bp 2930 bp 
p1684Sa02
a 
TET, SUL, TMP, 4GC HI2 
dfrA1-aadA1  
(1586 bp) 
5081 bp 2805 bp 2930 bp 
p04-9275
a TET, SUL, TMP, STR, 
4GC 
HI2 
dfrA12-orfF-
aadA2 (1913 bp) 
5408 bp 2805 bp 2930 bp 
p1443 
TET, SUL, TMP, STR, 
KAN, 4GC 
HI1 
dfrA17-aadA5 
(1664 bp) 
ca. 5 kb ca. 2.8 kb ca. 2.9 kb 
p1454 
TET, SUL, TMP, STR, 
KAN, 4GC 
HI1 
dfrA17-aadA5 
(1664 bp) 
ca. 5 kb ca. 2.8 kb ca. 2.9 kb 
p2657 
TET, SUL, TMP, STR, 
KAN, 4GC 
HI1 
dfrA17-aadA5 
(1664 bp) 
ca. 5 kb ca. 2.8 kb ca. 2.9 kb 
p3744 
TET, SUL, TMP, STR, 
KAN, 4GC 
HI1 
dfrA17-aadA5 
(1664 bp) 
ca. 5 kb ca. 2.8 kb ca. 2.9 kb 
p4410 
SUL, TMP, STR, KAN, 
4GC 
FIB 
dfrA1-aadA1  
(1586 bp) 
ca. 15-20 kb ca. 2.8 kb ca. 2.9 kb 
a 
pB4-25: blaCTX-M-2-carrying plasmid isolated from E. coli, poultry, Belgium, 2008
5
  137 
  p1684Sa02: blaCTX-M-2-carrying plasmid isolated from Salmonella enterica serovar Virchow (genbank accession number EF592570), poultry, 138 
Belgium, 2002
3 
139 
  p04-9275: blaCTX-M-2-carrying plasmid isolated from Salmonella enterica serovar Typhimurium (genbank accession number EF592571), human 140 
(gastroenteritis), French Guiana, 2004
1
       141 
b 
Antimicrobial susceptibility testing of the E. coli isolates was assessed by the disc diffusion method (Kirby-Bauer) and interpreted according to 142 
the guidelines of the Antibiogram Committee of the French Society for Microbiology (CA-SFM). Antimicrobial drugs used were the following: 143 
tetracycline (TET), sulphonamides (SUL), trimethoprim (TMP), streptomycin (STR), kanamycin (KAN) and fourth-generation cephalosporins 144 
(4GC). 145 
c
 dfrA: gene encoding resistance to trimethoprim 146 
  aadA: gene encoding resistance to streptomycin 147 
 148 
